Purchases and Sales Made in Q2 2022 in Can Fite Bio Pharma Ltd. (CANF)
This table provides information about the institutional ownership of Can Fite Bio Pharma Ltd. (CANF) during Q2 2022. The information is specifically focused on institutions that hold shares of Can-Fite BioPharma Ltd..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 09, 2022
Q2 2022
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
56.3KNew |
$46.7K - $69.8K
|
56.3K
$91.2K
|
|
Aug 15, 2022
Q2 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
46.7KNew |
$38.7K - $57.9K
|
46.7K
$75.6K
|
|
Aug 15, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
34.1K+ 11.21% |
$28.3K - $42.3K
|
338K
$548K
|
|
Oct 27, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
34.1K+ 11.21% |
$28.3K - $42.3K
|
338K
$548K
|
|
Aug 10, 2022
Q2 2022
|
Ubs Group Ag
|
BUY
|
- |
340+ 4.73% |
$282 - $422
|
7.52K
$12.2K
|
|
Aug 09, 2022
Q2 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 12, 2022
Q2 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-1.5KClosed |
$1.25K - $1.86K
|
0
$0
|
|
Aug 15, 2022
Q2 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-11.3KClosed |
$9.41K - $14.1K
|
0
$0
|